Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRIMedical - Devices
+$0.84 today
- Market cap
- $1.35B
- Beta
- 2.18
- P/E (TTM)
- -34.3
- EPS (TTM)
- -$0.28
Volume 0.26M
Average 0.92M
LMRI Tax Payables
Taxes owed to authorities that have not yet been paid.
Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI
Tax Payables · Q1 FY2026 · quarter ended Mar 2026
Tax payables of $0 in Q1 FY2026
Q1 FY2026 tax payables was $0.
Context
- Tax payables amounted to 0.0% of total assets at the end of Q1 FY2026.
- Tax payables increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Tax Payables history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Tax Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 4.04M | +830.0% |
| FY2023 | 2023-12-31 | 434K | — |
Tax Payables vs competitors
How LMRI compares with its peers on the latest reported figures
- LMRI's Mar 2026 tax payables of $0 is the highest of the 2 companies compared; the peer median is $0.
- Tax payables amounts to 0.0% of total assets for LMRI, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LMRILumexa Imaging Holdings, Inc. Common Stock | Mar 2026 | $0 | — | — | 0.0% |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LMRI) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
Intrinsic Alpha fair value
Locked
Current Price
$14.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.